Restoration of Physiologically Responsive Low-Density Lipoprotein Receptor-Mediated Endocytosis in Genetically Deficient Induced Pluripotent Stem Cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ramakrishnan, Venkat M ^a,b   Yang, Jeong Yeh ^c,d   Tien, Kevin T ^a   McKinley, Thomas R ^a   Bocard, Braden R ^a,e   Maijub, John G ^a,b   Burchell, Patrick O ^a   Williams, Stuart K ^a,b   Morris, Marvin E ^a,b   Hoying, James B ^a,b   Wade Martins, Richard ^f   West, Franklin D ^c,d   Boyd, Nolan L ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e GEORGETOWN COLLEGE   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ADMINISTRATION AND DOSAGE; CELL CULTURE; CELL DIFFERENTIATION; CONVALESCENCE; ENDOCYTOSIS; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC ENHANCEMENT; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; PATHOLOGY; PHYSIOLOGY; PLASMID; PROCEDURES;

CELL DIFFERENTIATION; CELLS, CULTURED; ENDOCYTOSIS; GENETIC ENHANCEMENT; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INDUCED PLURIPOTENT STEM CELLS; PLASMIDS; RECEPTORS, LDL; RECOVERY OF FUNCTION;

EID: 84940035312     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13231     Document Type: Article

References (45)

1. Takahashi, K., Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126, 663-676, doi: 10.1016/j.cell.2006.07.024 (2006).
2. Rader, D. J., Cohen, J., Hobbs, H. H. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest. 111, 1795-1803, doi: 10.1172/jci200318925 (2003).
3. Benn, M., Watts, G. F., Tybjaerg-Hansen, A., Nordestgaard, B. G. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 97, 3956-3964, doi: 10.1210/jc.2012-1563 (2012).
4. Nordestgaard, B. G. et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 34, 3478-3490a, doi: 10.1093/eurheartj/eht273 (2013).
5. Bilheimer, D. W., Goldstein, J. L., Grundy, S. M., Starzl, T. E., Brown, M. S. Liver transplantation to provide low-densitylipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med. 311, 1658-1664, doi: 10.1056/NEJM198412273112603 (1984).
6. Kim, W. R. et al. OPTN/SRTR 2012 Annual Data Report: liver. Am J Transplant. 14, 69-96, doi: 10.1111/ajt.12581 (2014).
7. Treyer, A., Müsch, A. Hepatocyte polarity. Compr Physiol. 3, 243-287, doi: 10.1002/cphy.c120009 (2013).
8. Hibbitt, O. C. et al. Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs. Mol Ther. 18, 317-326, doi: 10.1038/mt.2009.249 (2010).
9. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 7, 618-630, doi: 10.1016/j.stem.2010.08.012 (2010).
10. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131, 861-872, doi: 10.1016/j.cell.2007.11.019 (2007).
11. Song, Z. et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 19, 1233-1242, doi: 10.1038/cr.2009.107 (2009).
12. Fattahi, F. et al. Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells. Mol Biotechnol. 54, 863-873, doi: 10.1007/s12033-012-9635-3 (2013).
13. Kakaei, F. et al. Liver transplantation for homozygous familial hypercholesterolemia: two case reports. Transplant Proc. 41, 2939-2941, doi: 10.1016/j.transproceed.2009.07.028 (2009).
14. Wiegand, B. D., Ketterer, S. G., Rapaport, E. The use of indocyanine green for the evaluation of hepatic function and blood flow in man. Am J Dig Dis. 5, 427-436 (1960).
15. Maijub, J. G. et al. Concentration Dependent Vascularization of Adipose Stromal Vascular Fraction Cells. Cell Transplant. In press, doi: 10.3727/096368914? 685401 (2014).
16. Nunes, S. S. et al. Generation of a functional liver tissue mimic using adipose stromal vascular fraction cell-derived vasculatures. Sci Rep. 3, 2141, doi: 10.1038/srep02141 (2013).
17. Grossman, M. et al. A pilot study of ex vivo gene therapy for homozygous familial hypecholesterolemia. Nat Med. 1, 1148-1154, doi: 10.1038/nm1195-1148 (1995).
18. Grossman, M. et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nat Genet. 6, 335-341, doi: 10.1038/ng0494-335 (1994).
19. Cichon, G. et al. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage. J Gene Med. 6, 166-175, doi: 10.1002/jgm.473 (2004).
20. Heeren, J., Weber, W., Beisiegel, U. Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. J Cell Sci. 112, 349-359 (1999).
21. Leight, E. R., Sugden, B. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. J Virol. 75, 10709-10720, doi: 10.1128/JVI.75.22.10709-10720.2001 (2001).
22. Leight, E. R., Sugden, B. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol. 21, 4149-4161, doi: 10.1128/MCB.21.13.4149-4161.2001 (2001).
23. Krieger, M., Brown, M. S., Goldstein, J. L. Isolation of Chinese Hamster Cell Mutants Defective in the Receptor-mediated Endocytosis of Low Density Lipoprotein. J Mol Biol. 150, 167-184 (1981).
24. Costa, M. et al. A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc. 2, 792-796, doi: 10.1038/nprot.2007.105 (2007).
25. Lufino, M. M., Manservigi, R., Wade-Martins, R. An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. Nucleic Acids Res. 35, e98, doi: 10.1093/nar/gkm570 (2007).
26. Boyd, N. L., Robbins, K. R., Dhara, S. K., West, F. D., Stice, S. L. Human Embryonic Stem Cell-Derived Mesoderm-Like Epithelium Transitions to Mesenchymal Progenitor Cells. Tissue Eng Part A. 15, 1897-1907, doi: 10.1089/ten.tea.2008.0351 (2009).
27. Maxfield, F. R., Menon, A. K. Intracellular sterol transport and distribution. Curr Opin Cell Biol. 18, 379-385, doi: 10.1016/j. ceb.2006.06.012 (2006).
28. González, F., Boué, S., Izpisuá Belmonte, J. C. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet. 12, 231-242, doi: 10.1038/nrg2937 (2011).
29. Rachid, S. T. et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest. 120, 3127-3136, doi: 10.1172/jci43122ds1 (2010).
30. Cayo, M. A. et al. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia. Hepatology. 56, 2163-2171, doi: 10.1002/hep.25871 (2012).
31. Jacobs, F., Van Craeyveld, E., Feng, Y., Snoeys, J., De Geest, B. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia. Atherosclerosis. 201, 289-297, doi: 10.1016/j.atherosclerosis.2008.02.023 (2008).
32. Stein, C. S., Martins, I., Davidson, B. L. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade. J Gene Med. 2, 41-51 (2000).
33. Kassim, S. H. et al. Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis. PLoS One. 5, doi: 10.1371/journal.pone.0013424. (2010).
34. Kassim, S. H. et al. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia. Hum Gene Ther. 24, 19-26, doi: 10.1089/hum.2012.108 (2013).
35. Li, C. Y. et al. Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues. Tissue Eng Part A. 20, 2200-2212, doi: 10.1089/ten.TEA.2013.0667 (2014).
36. Löser, P., Jennings, G. S., Strauss, M., Sandig, V. Reactivation of the Previously Silenced Cytomegalovirus Major Immediate-Early Promoter in the Mouse Live: Involvement of NFkB. J Virol. 72, 180-190 (1998).
37. Thomas, C. E., Ehrhardt, A., Kay, M. A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003, 5, doi: 10.1038/nrg1066 (2003).
38. Kozarsky, K. F. et al. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem. 269, 13695-13702 (1994).
39. Van Craeyveld, E., Jacobs, F., Gordts, S. C., De Geest, B. Gene therapy for familial hypercholesterolemia. Curr Pharm Des. 17, 2575-2591, doi: 10.2174/138161211797247550 (2011).
40. Yates, J. L., Camiolo, S. M., Bashaw, J. M. The minimal replicator of Epstein-Barr virus oriP. J Virol. 74, 4512-4522 (2000).
41. Levitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A., Masucci, M. G. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA. 94, 12616-12621 (1997).
42. Russell, D. W. et al. cDNA cloning of the bovine low density lipoprotein receptor: feedback regulation of a receptor mRNA. Proc Natl Acad Sci USA. 80, 7501-7505 (1983).
43. Li, J. et al. In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene. J Clin Invest. 95, 768-773, doi: 10.1172/JCI117725 (1995).
44. Yates, J. L., Guan, N. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol. 65, 483-488 (1991).
45. Goldstein, J. L., Brown, M. S. Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts. J Biol Chem. 249, 5153-5162 (1974).